Elisabet Pujadas

Dr. Elisabet Pujadas

orcid

Research Focus & Metrics

Academic Career Length

18Years (2009-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 March 2012 in Cell
Verified
Journal Article
Closed access
EPElisabet Pujadas
Elisabet Pujadas
AFAndrew P. Feinberg
Andrew P. Feinberg

1 October 2009 in Immunity
Verified
Journal Article
Closed access
CSChauncey J. Spooner
Chauncey J. Spooner
JCJason X. Cheng
Jason X. Cheng
EPElisabet Pujadas
Elisabet Pujadas
PLPeter Laslo
Peter Laslo
HSHarinder Singh
Harinder Singh

27 March 2017 in Nature Genetics
Verified
Journal Article
Open access
PDF file
GJGarrett Jenkinson
Garrett Jenkinson
EPElisabet Pujadas
Elisabet Pujadas
JGJohn Goutsias
John Goutsias
AFAndrew P Feinberg
Andrew P Feinberg
Andrew Feinberg, John Goutsias and colleagues derive potential energy landscapes from bisulfite sequencing data and quantify DNA methylation stochasticity genome-wide using Shannon's entropy, identifying an association between entropy and chromatin structure. Their analysis highlights the information-theoretic nature of the epigenome and provides a methodology for studying its role in disease and aging. Epigenetics is the study of biochemical modifications carrying information independent of DNA sequence, which are heritable through cell division. In 1940, Waddington coined the term “epigenetic landscape” as a metaphor for pluripotency and differentiation, but methylation landscapes have not yet been rigorously computed. Using principles from statistical physics and information theory, we derive epigenetic energy landscapes from whole-genome bisulfite sequencing (WGBS) data that enable us to quantify methylation stochasticity genome-wide using Shannon's entropy, associating it with chromatin structure. Moreover, we consider the Jensen–Shannon distance between sample-specific energy landscapes as a measure of epigenetic dissimilarity and demonstrate its effectiveness for discerning epigenetic differences. By viewing methylation maintenance as a communications system, we introduce methylation channels and show that higher-order chromatin organization can be predicted from their informational properties. Our results provide a fundamental understanding of the information-theoretic nature of the epigenome that leads to a powerful approach for studying its role in disease and aging.

22 May 2020 in Journal of Medical Virology
Verified
Journal Article
Closed access
PDF file
EPElisabet Pujadas
Elisabet Pujadas
NINnaemeka Ibeh
Nnaemeka Ibeh
MHMatthew M. Hernandez
Matthew M. Hernandez
AWAneta Waluszko
Aneta Waluszko
TSTatyana Sidorenko
Tatyana Sidorenko
MGMelissa Randy Gitman
Melissa Randy Gitman

20 January 2021 in American Journal of Surgical Pathology
Verified
Journal Article
Closed access
SSSwati Satturwar
Swati Satturwar
MFMary Fowkes
Mary Fowkes
CFCarol Farver
Carol Farver
AWAllecia M. Wilson
Allecia M. Wilson
Albino EccherAlbino Eccher
Albino Eccher
LPLiron Md Pantanowitz
Liron Md Pantanowitz
Coronavirus Disease 2019 (COVID-19), caused by the novel Severe Acute Respiratory Syndrome–associated Coronavirus 2 (SARS-CoV-2), has become a global threat to public health. COVID-19 is more pathogenic and infectious than the prior 2002 pandemic caused by SARS-CoV-1. The pathogenesis of certain disease manifestations in COVID-19 such as diffuse alveolar damage (DAD) are thought to be similar to SARS-CoV-1. However, the exact pathogenesis of COVID-19 related deaths remains poorly understood. The aim of this article was to systematically summarize the rapidly emerging literature regarding COVID-19 autopsies. A meta-analysis was also conducted based on data accrued from preprint and published articles on COVID-19 (n=241 patients) and the results compared with postmortem findings associated with SARS-CoV-1 deaths (n=91 patients). Both autopsy groups included mostly adults of median age 70 years with COVID-19 and 50 years with SARS-CoV-1. Overall, prevalence of DAD was more common in SARS-CoV-1 (100.0%) than COVID-19 (80.9%) autopsies (P=0.001). Extrapulmonary findings among both groups were not statistically significant except for hepatic necrosis (P <0.001), splenic necrosis (P<0.006) and white pulp depletion (P <0.001) that were more common with SARS-CoV-1. Remarkable postmortem findings in association with COVID-19 apart from DAD include pulmonary hemorrhage, viral cytopathic effect within pneumocytes, thromboembolism, brain infarction, endotheliitis, acute renal tubular damage, white pulp depletion of the spleen, cardiac myocyte necrosis, megakaryocyte recruitment, and hemophagocytosis.

30 June 2021 in Communications Medicine
Verified
Journal Article
Open access
PDF file
TJTomi Jun
Tomi Jun
SNSharon Nirenberg
Sharon Nirenberg
TWTziopora Weinberger
Tziopora Weinberger
NSNavya Sharma
Navya Sharma
EPElisabet Pujadas
Elisabet Pujadas
KHKuan-lin Huang
Kuan-lin Huang
Background: Sex has consistently been shown to affect COVID-19 mortality, but it remains unclear how each sex’s clinical outcome may be distinctively shaped by risk factors. Methods: We studied a primary cohort of 4930 patients hospitalized with COVID-19 in a single healthcare system in New York City from the start of the pandemic till August 5, 2020, and a validation cohort of 1645 patients hospitalized with COVID-19 in the same healthcare system from August 5, 2020, to January 13, 2021. Results: Here we show that male sex was independently associated with in-hospital mortality, intubation, and ICU care after adjusting for demographics and comorbidities. Using interaction analysis and sex-stratified models, we found that hypoxia interacted with sex to preferentially increase women’s mortality risk while obesity interacted with sex to preferentially increase women’s risk of intubation and intensive care in our primary cohort. In the validation cohort, we observed that male sex remained an independent risk factor for mortality, but sex-specific interactions were not replicated. Conclusions: We conducted a comprehensive sex-stratified analysis of a large cohort of hospitalized COVID-19 patients, highlighting clinical factors that may contribute to sex differences in the outcome of COVID-19.